Novavax testing new version of COVID-19 vaccine
Biotechnology company Novavax says it’s testing a new version of its COVID-19 vaccine. Scientists are specifically targeting the coronavirus variant first identified in South Africa.
Novavax: Large study finds COVID-19 shot about 90% effective
By Linda A. Johnson
Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico, potentially offering the world yet another weapon against the virus at a time when developing countries are desperate for doses.
